Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ASPRUZYO SPRINKLE safely and effectively. See full prescribing information for ASPRUZYO SPRINKLE. ASPRUZYO SPRINKLE TM(ranolazine) extended-release granules, for oral use Initial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
ASPRUZYO Sprinkle is indicated for the treatment of chronic angina. ASPRUZYO Sprinkle may be used with beta-blockers, nitrates, calcium channel blockers, anti‑platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.
- generic_name
- ranolazine
- product_names
- Ranolazine
- ndc
- 47335-624, 47335-625, 47335-624-30, 47335-624-60, 47335-624-11, 47335-625-30, 47335-625-60, 47335-625-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en